MeSH term
Frequency | Condition_Probility | *Cleavage Stage, Ovum | 2 | 1.0 |
Embryo Transfer/*standards | 2 | 1.0 |
Female | 149 | 0.0 |
Humans | 439 | 0.0 |
Meta-Analysis | 2 | 1.0 |
Pregnancy | 4 | 0.0 |
Pregnancy Outcome | 3 | 1.0 |
Pregnancy Rate | 2 | 1.0 |
Pregnancy, Multiple | 2 | 1.0 |
Randomized Controlled Trials | 2 | 0.0 |
Review Literature | 2 | 1.0 |
Adult | 99 | 0.0 |
Incidence | 2 | 0.0 |
Male | 135 | 0.0 |
Middle Aged | 115 | 0.0 |
Reference Values | 15 | 0.0 |
Risk Factors | 3 | 0.0 |
English Abstract | 12 | 0.0 |
Diagnosis, Differential | 8 | 0.0 |
Aged | 101 | 0.0 |
Aged, 80 and over | 43 | 0.0 |
CA-15-3 Antigen/biosynthesis | 2 | 18.0 |
Immunohistochemistry | 109 | 0.0 |
Mucins/*biosynthesis | 17 | 44.0 |
Paget's Disease, Extramammary/*metabolism/pathology | 3 | 60.0 |
Penis/metabolism/pathology | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 273 | 0.0 |
Scrotum/metabolism/pathology | 2 | 100.0 |
Tumor Markers, Biological/*biosynthesis | 3 | 3.0 |
Vulva/metabolism/pathology | 2 | 100.0 |
Disease Progression | 9 | 0.0 |
Immunoenzyme Techniques | 44 | 1.0 |
Keratin/metabolism | 3 | 2.0 |
Metaplasia | 16 | 17.0 |
Mucins/metabolism | 9 | 18.0 |
Phenotype | 30 | 0.0 |
Precancerous Conditions/metabolism/pathology | 3 | 20.0 |
Protein p53/*metabolism | 3 | 0.0 |
CA-15-3 Antigen/metabolism | 9 | 28.0 |
*Helicobacter pylori | 3 | 2.0 |
Lewis Blood-Group System/*metabolism | 2 | 25.0 |
Mucins/*metabolism | 42 | 42.0 |
Base Sequence | 55 | 0.0 |
Carcinoma, Squamous Cell | 2 | 1.0 |
DNA Primers | 19 | 0.0 |
Enzyme Inhibitors/pharmacology | 6 | 0.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Lung Neoplasms | 2 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 3 | 0.0 |
Mucins/biosynthesis/*genetics | 9 | 52.0 |
Polymerase Chain Reaction | 23 | 0.0 |
Tumor Cells, Cultured | 59 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Line | 20 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Colonic Neoplasms/genetics/metabolism | 3 | 21.0 |
Dose-Response Relationship, Drug | 12 | 0.0 |
Luciferases/metabolism | 3 | 0.0 |
Models, Biological | 3 | 0.0 |
Mucins/*biosynthesis/genetics | 10 | 45.0 |
Mutation | 7 | 0.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
RNA/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 45 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 79 | 0.0 |
Signal Transduction | 6 | 0.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 3 | 0.0 |
Time Factors | 15 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Transcription, Genetic | 15 | 0.0 |
*Up-Regulation | 3 | 1.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
Microsatellite Repeats/*genetics | 2 | 0.0 |
Neoplasm Proteins/analysis | 7 | 2.0 |
Neoplasm Staging | 16 | 0.0 |
Survival Analysis | 8 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 4 | 1.0 |
Neoplasm Proteins/genetics | 6 | 1.0 |
RNA, Messenger/metabolism | 34 | 0.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
CA-15-3 Antigen/analysis | 5 | 8.0 |
Lymphatic Metastasis | 8 | 0.0 |
Mucins/*analysis | 17 | 44.0 |
Adenocarcinoma, Mucinous/*classification/metabolism/pathology | 2 | 100.0 |
Cell Division | 9 | 0.0 |
Neoplasm Invasiveness | 12 | 1.0 |
Neoplasm Proteins/metabolism | 8 | 2.0 |
Treatment Outcome | 7 | 0.0 |
Tumor Markers, Biological/*metabolism | 11 | 2.0 |
Animals | 68 | 0.0 |
Gene Expression Regulation | 12 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Mice | 33 | 0.0 |
Mucus/secretion | 2 | 25.0 |
Rats | 18 | 0.0 |
Respiratory Mucosa/metabolism | 4 | 26.0 |
Antigens, Tumor-Associated, Carbohydrate/*analysis | 3 | 10.0 |
Comparative Study | 58 | 0.0 |
Follow-Up Studies | 5 | 0.0 |
Mucins/analysis | 12 | 33.0 |
Oligosaccharides/analysis | 2 | 8.0 |
Predictive Value of Tests | 4 | 0.0 |
Prognosis | 29 | 0.0 |
Survival Rate | 15 | 0.0 |
Conjunctiva/*metabolism | 2 | 14.0 |
Epithelial Cells/metabolism | 7 | 2.0 |
Goblet Cells/*metabolism | 3 | 50.0 |
Mucins/*physiology | 2 | 15.0 |
Tears/metabolism | 2 | 28.0 |
CA-15-3 Antigen/*metabolism | 12 | 22.0 |
Gastrectomy | 2 | 3.0 |
Peptide Fragments/*metabolism | 4 | 2.0 |
Blotting, Northern | 27 | 0.0 |
*DNA Methylation | 4 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 20 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Mucins/*biosynthesis/*genetics | 5 | 100.0 |
Pancreatic Neoplasms/*metabolism | 4 | 5.0 |
Plasmids/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 38 | 0.0 |
Transfection | 10 | 0.0 |
Carcinoma/metabolism/pathology | 2 | 11.0 |
Gastric Mucosa/metabolism/pathology | 4 | 19.0 |
Gastroscopy | 2 | 4.0 |
Metaplasia/metabolism/pathology | 3 | 37.0 |
Mucins/classification/*metabolism | 4 | 100.0 |
Adenocarcinoma/classification/*metabolism/secondary | 2 | 100.0 |
Retrospective Studies | 13 | 0.0 |
Stomach Neoplasms/classification/*metabolism/pathology | 2 | 66.0 |
Tumor Markers, Biological | 14 | 3.0 |
Chronic Disease | 9 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 14 | 0.0 |
*Gene Expression | 15 | 1.0 |
Mucins/analysis/*genetics | 10 | 66.0 |
Probability | 3 | 0.0 |
Prospective Studies | 4 | 0.0 |
RNA, Messenger/analysis | 24 | 0.0 |
Sensitivity and Specificity | 9 | 0.0 |
Gastric Mucosa/metabolism/*pathology | 2 | 20.0 |
Gene Expression | 44 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
CA-15-3 Antigen/*biosynthesis | 7 | 28.0 |
Colorectal Neoplasms/*metabolism/pathology | 6 | 12.0 |
Protein p53/*biosynthesis | 2 | 1.0 |
Keratin/analysis | 2 | 0.0 |
Adenoma/*metabolism/pathology | 3 | 8.0 |
Carcinoma/*metabolism/pathology | 2 | 3.0 |
Carcinoma in Situ/metabolism/pathology | 3 | 30.0 |
Epithelial Cells/metabolism/pathology | 3 | 6.0 |
Ki-67 Antigen/analysis | 4 | 1.0 |
Carbohydrate Sequence | 9 | 2.0 |
DNA, Complementary | 9 | 0.0 |
Mass Fragmentography | 2 | 0.0 |
Molecular Sequence Data | 97 | 0.0 |
Rats, Sprague-Dawley | 4 | 0.0 |
Epithelium/metabolism | 14 | 3.0 |
Gallbladder/*metabolism | 4 | 30.0 |
*In Situ Hybridization | 2 | 14.0 |
Mucins/*genetics | 55 | 50.0 |
Stomach Neoplasms/metabolism/*pathology | 7 | 21.0 |
Antibodies, Monoclonal/diagnostic use | 3 | 0.0 |
Antigens, Neoplasm/immunology | 2 | 1.0 |
Glycosylation | 39 | 3.0 |
Mucins/*immunology | 5 | 22.0 |
Paraffin Embedding | 2 | 0.0 |
Blotting, Western | 22 | 0.0 |
Cystic Fibrosis/metabolism | 2 | 6.0 |
Electrophoresis, Agar Gel | 4 | 0.0 |
Mucins/*chemistry/metabolism | 3 | 42.0 |
Gastric Mucosa/pathology | 3 | 7.0 |
*Gene Expression Regulation, Neoplastic | 12 | 0.0 |
In Situ Hybridization | 42 | 1.0 |
Stomach Neoplasms/*genetics | 2 | 1.0 |
Adenocarcinoma/*genetics | 6 | 4.0 |
Pancreatic Neoplasms/*genetics | 2 | 2.0 |
Tumor Markers, Biological/*analysis | 19 | 1.0 |
CA-15-3 Antigen/*analysis | 6 | 35.0 |
Protein p53/analysis | 4 | 1.0 |
Barrett Esophagus/*pathology | 2 | 40.0 |
Biological Markers/analysis | 3 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Intermediate Filament Proteins/analysis | 2 | 5.0 |
Intestines/*pathology | 3 | 23.0 |
Keratin/*analysis | 2 | 6.0 |
Stomach/*pathology | 2 | 28.0 |
Adenocarcinoma/*metabolism | 4 | 4.0 |
Adenoma/*metabolism | 2 | 3.0 |
Colon/metabolism | 10 | 9.0 |
Colorectal Neoplasms/*metabolism | 2 | 4.0 |
Intestinal Mucosa/metabolism | 6 | 5.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Mucins/genetics/*metabolism | 20 | 52.0 |
Neoplasm Proteins/*metabolism | 10 | 1.0 |
Precancerous Conditions/metabolism | 2 | 12.0 |
Breast Neoplasms/*metabolism/pathology | 3 | 1.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Cells, Cultured | 14 | 0.0 |
Bile Duct Neoplasms/*metabolism | 2 | 33.0 |
RNA, Neoplasm/metabolism | 2 | 2.0 |
Case-Control Studies | 10 | 0.0 |
*Chromosomes, Human, Pair 11 | 5 | 0.0 |
Colorectal Neoplasms/*genetics | 3 | 1.0 |
Genetic Markers | 3 | 0.0 |
Immunohistochemistry/methods | 10 | 1.0 |
Statistics, Nonparametric | 2 | 0.0 |
CA-15-3 Antigen/*analysis/genetics | 3 | 33.0 |
Mucins/*analysis/genetics | 4 | 50.0 |
Cell Differentiation/physiology | 5 | 1.0 |
Down-Regulation | 4 | 0.0 |
HT29 Cells | 9 | 4.0 |
Mice, Nude | 10 | 0.0 |
Mucins/biosynthesis | 7 | 58.0 |
Transplantation, Heterologous | 5 | 0.0 |
Centrifugation | 2 | 2.0 |
Centrifugation, Density Gradient | 7 | 2.0 |
Chromatography, Gel | 6 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 15 | 0.0 |
Mucins/*chemistry/*metabolism | 2 | 66.0 |
Protein Binding | 10 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Salivary Glands/*metabolism | 2 | 14.0 |
Trachea/metabolism | 5 | 27.0 |
Genes, Structural/*genetics | 2 | 0.0 |
Protein Isoforms/genetics | 2 | 0.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
Respiratory Mucosa/*metabolism | 2 | 14.0 |
Disease Models, Animal | 3 | 0.0 |
Mucins/*genetics/metabolism | 19 | 67.0 |
Biological Markers | 5 | 0.0 |
Cell Differentiation | 12 | 0.0 |
Gastric Mucin/analysis | 3 | 100.0 |
Multivariate Analysis | 2 | 0.0 |
Neoplasm Proteins/*analysis | 5 | 1.0 |
Organ Specificity | 4 | 0.0 |
Proportional Hazards Models | 2 | 0.0 |
Adolescent | 16 | 0.0 |
Intestinal Mucosa/*metabolism/pathology | 2 | 12.0 |
Staining and Labeling/methods | 2 | 1.0 |
Adenocarcinoma/*metabolism/pathology | 4 | 3.0 |
Gastritis/pathology | 2 | 33.0 |
Stomach Neoplasms/*metabolism/pathology | 6 | 10.0 |
Alleles | 2 | 0.0 |
Amino Acid Sequence | 65 | 0.0 |
Bronchi/metabolism | 2 | 8.0 |
Cloning, Molecular | 15 | 0.0 |
Cysteine | 2 | 1.0 |
Gene Library | 2 | 0.0 |
Mucins/*chemistry/*genetics | 2 | 100.0 |
Repetitive Sequences, Amino Acid | 4 | 3.0 |
Restriction Mapping | 7 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Antibodies, Monoclonal | 23 | 0.0 |
Gastric Mucin/*metabolism | 6 | 75.0 |
Tumor Markers, Biological/metabolism | 15 | 3.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Gastric Mucin/biosynthesis | 4 | 100.0 |
Neprilysin/biosynthesis | 3 | 30.0 |
Oligosaccharides/chemistry | 2 | 7.0 |
*Repetitive Sequences, Amino Acid | 3 | 15.0 |
Gastric Mucin/chemistry/metabolism | 2 | 100.0 |
Gastric Mucosa/immunology/pathology | 2 | 22.0 |
Cell Transformation, Neoplastic | 7 | 1.0 |
Child | 15 | 0.0 |
Mucins/analysis/*biosynthesis | 3 | 75.0 |
Adenocarcinoma, Mucinous/*metabolism/pathology | 5 | 71.0 |
Carcinoma, Pancreatic Ductal/*metabolism/pathology | 3 | 27.0 |
Pancreatic Neoplasms/*metabolism/pathology | 3 | 6.0 |
Staining and Labeling | 4 | 0.0 |
Chromosome Mapping | 9 | 0.0 |
Gene Expression Regulation, Neoplastic/physiology | 2 | 1.0 |
Intestinal Mucosa/pathology | 3 | 5.0 |
Tandem Repeat Sequences | 3 | 2.0 |
Fluorometry | 2 | 2.0 |
Adenocarcinoma, Mucinous/genetics/*metabolism | 2 | 100.0 |
CpG Islands | 2 | 0.0 |
*Gene Expression Regulation | 8 | 0.0 |
Goblet Cells/metabolism | 3 | 60.0 |
Intestines/*metabolism | 3 | 4.0 |
Neoplasm Transplantation | 3 | 0.0 |
Epitopes/metabolism | 2 | 3.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
Mucins/*chemistry/immunology/*metabolism | 2 | 100.0 |
Rats, Wistar | 2 | 0.0 |
Tissue Distribution | 7 | 0.0 |
Biopsy, Needle | 3 | 0.0 |
Carcinoma in Situ/*chemistry | 2 | 50.0 |
Culture Techniques | 4 | 0.0 |
CA-15-3 Antigen/genetics/*metabolism | 3 | 20.0 |
Culture Media | 4 | 0.0 |
Gene Expression Regulation/*drug effects | 4 | 0.0 |
Hydrogen-Ion Concentration | 3 | 0.0 |
Intestinal Mucosa/*metabolism | 5 | 6.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Disease-Free Survival | 2 | 0.0 |
Mucins/*genetics/*metabolism | 6 | 75.0 |
Respiratory Mucosa/metabolism/pathology | 2 | 28.0 |
Adenocarcinoma/*genetics/pathology | 2 | 2.0 |
RNA, Messenger/genetics | 18 | 0.0 |
Gestational Age | 5 | 0.0 |
Receptors, Retinoic Acid/metabolism | 2 | 2.0 |
Tretinoin/pharmacology | 3 | 0.0 |
Carcinoma, Squamous Cell/*metabolism/pathology | 2 | 2.0 |
Precancerous Conditions/*metabolism/pathology | 2 | 9.0 |
Antigens, Tumor-Associated, Carbohydrate/*biosynthesis/metabolism | 2 | 100.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Isoenzymes/metabolism | 3 | 0.0 |
N-Acetylgalactosaminyltransferases/*metabolism | 3 | 60.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 1.0 |
Antibodies, Monoclonal/immunology | 6 | 0.0 |
Epitopes | 9 | 1.0 |
Rabbits | 6 | 0.0 |
Antigens, Tumor-Associated, Carbohydrate/*metabolism | 2 | 10.0 |
Keratin/*metabolism | 4 | 12.0 |
Antigens, Differentiation/*biosynthesis/genetics | 2 | 16.0 |
CA-15-3 Antigen/biosynthesis/genetics | 2 | 66.0 |
RNA, Messenger/biosynthesis | 6 | 0.0 |
Protein p53/genetics/metabolism | 3 | 3.0 |
Gastric Mucosa/*metabolism/pathology | 3 | 23.0 |
Histocytochemistry | 5 | 0.0 |
RNA, Messenger/*metabolism | 5 | 0.0 |
Intestinal Mucosa/chemistry/*pathology | 2 | 40.0 |
Stomach Neoplasms/chemistry/classification/*pathology | 2 | 66.0 |
Tumor Markers, Biological/analysis | 10 | 1.0 |
Adenocarcinoma/metabolism | 3 | 4.0 |
Pancreas/*metabolism | 2 | 5.0 |
Stomach/embryology/*metabolism/pathology | 2 | 100.0 |
Stomach Neoplasms/*metabolism | 5 | 11.0 |
Cervix Neoplasms/*chemistry/pathology | 2 | 25.0 |
Adenocarcinoma/*genetics/metabolism | 2 | 5.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Growth Substances/*metabolism | 3 | 2.0 |
*Muscle Proteins | 13 | 4.0 |
*Neuropeptides | 13 | 10.0 |
Peptides/*metabolism | 6 | 3.0 |
Barrett Esophagus/genetics/*metabolism | 2 | 100.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Cell Count | 5 | 0.0 |
Gene Expression/drug effects | 3 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Methotrexate/*pharmacology | 3 | 6.0 |
Mucins/genetics | 7 | 36.0 |
Proteins/genetics | 2 | 0.0 |
*Genes, ras | 2 | 0.0 |
Multigene Family | 3 | 0.0 |
Adenocarcinoma/metabolism/*pathology | 7 | 12.0 |
Adenoma/metabolism/*pathology | 2 | 15.0 |
Antibodies, Monoclonal/immunology/metabolism | 2 | 4.0 |
Antibody Specificity | 7 | 0.0 |
Mucins/*biosynthesis/immunology | 2 | 100.0 |
Epithelial Cells/cytology/physiology | 2 | 6.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
DNA, Neoplasm/analysis | 5 | 0.0 |
Genes, p53 | 2 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Antigens, Tumor-Associated, Carbohydrate/genetics/immunology/*metabolism | 2 | 100.0 |
Up-Regulation | 5 | 0.0 |
Carcinogens/*pharmacology | 2 | 3.0 |
Drug Combinations | 2 | 0.0 |
Neoplasm Proteins/*biosynthesis/genetics | 2 | 1.0 |
RNA, Neoplasm/biosynthesis/genetics | 3 | 5.0 |
Adenoma/chemistry | 2 | 15.0 |
Centrifugation, Isopycnic | 3 | 37.0 |
Immunoblotting | 8 | 0.0 |
Inflammatory Bowel Diseases/genetics/*metabolism | 2 | 66.0 |
Flow Cytometry | 4 | 0.0 |
*Gene Expression Regulation/drug effects | 2 | 1.0 |
Lung/*cytology | 2 | 6.0 |
CA-15-3 Antigen/genetics/metabolism | 2 | 33.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Acute Disease | 2 | 0.0 |
Digestive Physiology | 2 | 8.0 |
Mucins/genetics/immunology/*metabolism | 3 | 60.0 |
Adenocarcinoma, Mucinous/metabolism/pathology | 2 | 66.0 |
Cell Line, Tumor | 5 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Circular Dichroism | 3 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Spectroscopy, Fourier Transform Infrared | 3 | 6.0 |
Neoplasm Proteins/biosynthesis/genetics | 5 | 3.0 |
Cell Adhesion | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Colorectal Neoplasms/metabolism/*pathology | 3 | 14.0 |
Neoplasm Proteins/*biosynthesis | 3 | 3.0 |
Colorectal Neoplasms/*genetics/pathology | 3 | 3.0 |
DNA Primers/chemistry | 4 | 0.0 |
DNA, Neoplasm/*analysis | 3 | 1.0 |
Lymph Nodes/pathology | 2 | 0.0 |
Neoplasm Proteins/*genetics | 6 | 0.0 |
Tumor Markers, Biological/*genetics | 3 | 2.0 |
Acetylgalactosamine/*metabolism | 2 | 28.0 |
Colonic Neoplasms/*metabolism/pathology | 5 | 12.0 |
Kinetics | 8 | 0.0 |
Mucins/chemistry/*metabolism | 2 | 25.0 |
Threonine/*metabolism | 2 | 4.0 |
Adenocarcinoma/*chemistry/pathology | 2 | 4.0 |
Colon/chemistry | 2 | 10.0 |
Colorectal Neoplasms/*chemistry/pathology | 2 | 12.0 |
Mice, Inbred BALB C | 3 | 0.0 |
*Tumor Suppressor Proteins | 3 | 0.0 |
RNA, Messenger/*analysis | 7 | 1.0 |
Neoplasm Invasiveness/pathology | 3 | 5.0 |
Epithelium/chemistry | 5 | 4.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Gastric Mucosa/metabolism | 3 | 6.0 |
Mucins/immunology/*metabolism | 2 | 50.0 |
Peptide Fragments/immunology | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Peptides/*genetics | 2 | 2.0 |
Colonic Neoplasms/metabolism/*pathology | 3 | 12.0 |
Epithelium/metabolism/pathology | 2 | 3.0 |
Intestinal Neoplasms | 2 | 66.0 |
Neoplasm Proteins/genetics/*metabolism | 2 | 1.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Biopsy | 4 | 0.0 |
Carcinoma/*metabolism | 5 | 6.0 |
Barrett Esophagus/*metabolism/pathology | 4 | 50.0 |
Mucins/analysis/*metabolism | 2 | 66.0 |
Microscopy, Confocal | 3 | 0.0 |
Antigens, Neoplasm/*metabolism | 2 | 2.0 |
Bile Duct Neoplasms/*classification/diagnosis/metabolism/pathology | 2 | 100.0 |
*Bile Ducts, Intrahepatic/metabolism/pathology | 2 | 100.0 |
Cholangiocarcinoma/*classification/diagnosis/metabolism/pathology | 2 | 100.0 |
Neuraminidase/metabolism | 2 | 6.0 |
Statistics | 3 | 0.0 |
Cystic Fibrosis/*metabolism | 4 | 8.0 |
Gels | 4 | 4.0 |
Molecular Weight | 12 | 0.0 |
Mucins/*secretion | 2 | 40.0 |
Respiratory System/*metabolism | 5 | 35.0 |
Solubility | 3 | 0.0 |
Sputum/*chemistry | 2 | 16.0 |
Isoenzymes/genetics/*metabolism | 2 | 2.0 |
Mucous Membrane/chemistry | 2 | 16.0 |
Child, Preschool | 7 | 0.0 |
Gallbladder/*metabolism/pathology | 2 | 66.0 |
Infant | 5 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Neoplasm Proteins/biosynthesis | 2 | 2.0 |
Carcinoma/*genetics/pathology | 2 | 3.0 |
DNA Mutational Analysis | 3 | 0.0 |
Colon/*metabolism | 5 | 9.0 |
Microscopy, Electron | 8 | 0.0 |
Hyperplasia | 5 | 1.0 |
Polyps/*metabolism/pathology | 2 | 40.0 |
Breast Neoplasms/*metabolism | 2 | 0.0 |
Carcinoma, Ductal, Breast/*metabolism | 2 | 18.0 |
Mucins/*biosynthesis/metabolism | 4 | 80.0 |
Precipitin Tests | 9 | 0.0 |
Colonic Neoplasms/*genetics/pathology | 3 | 6.0 |
Dimethyl Sulfoxide/pharmacology | 2 | 2.0 |
Tetradecanoylphorbol Acetate/pharmacology | 4 | 0.0 |
Hyperplasia/metabolism/pathology | 2 | 14.0 |
Precancerous Conditions/metabolism/*pathology | 2 | 16.0 |
Liver Neoplasms/*chemistry | 2 | 8.0 |
Precancerous Conditions/*chemistry | 2 | 28.0 |
Protein Conformation | 8 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Colonic Neoplasms/*genetics | 2 | 2.0 |
Mucins/biosynthesis/genetics | 2 | 100.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Amino Acids/analysis | 7 | 2.0 |
Antibodies/metabolism | 2 | 2.0 |
Colon/*chemistry | 3 | 13.0 |
Glycopeptides/chemistry | 2 | 40.0 |
Monosaccharides/analysis | 2 | 28.0 |
Mucins/*chemistry/immunology | 3 | 75.0 |
Adenocarcinoma, Papillary/metabolism/pathology | 2 | 66.0 |
Pancreas/chemistry/pathology | 2 | 25.0 |
Pancreatic Neoplasms/metabolism/*pathology | 2 | 6.0 |
Helicobacter pylori | 3 | 7.0 |
CA-15-3 Antigen/genetics | 5 | 35.0 |
Chromosomes, Human, Pair 11 | 4 | 1.0 |
Dinoprostone/metabolism | 2 | 2.0 |
Goblet Cells/*physiology | 2 | 100.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Image Processing, Computer-Assisted | 3 | 0.0 |
Lung Neoplasms/*metabolism | 3 | 3.0 |
Colitis, Ulcerative/*metabolism | 3 | 17.0 |
Peptide Mapping | 3 | 0.0 |
E-Selectin/metabolism | 2 | 4.0 |
DNA Probes | 9 | 0.0 |
RNA, Messenger/genetics/metabolism | 9 | 0.0 |
Models, Molecular | 3 | 0.0 |
Mucins/*chemistry/*immunology/metabolism | 2 | 100.0 |
Bronchi/*cytology | 2 | 13.0 |
Cell Differentiation/drug effects | 6 | 0.0 |
Epithelial Cells/cytology | 2 | 2.0 |
Gene Expression/*drug effects | 2 | 0.0 |
Membrane Proteins/genetics | 2 | 0.0 |
*Phenotype | 2 | 0.0 |
Antibodies, Monoclonal/analysis | 2 | 2.0 |
Barrett Esophagus/*metabolism | 3 | 60.0 |
Epitopes/analysis | 8 | 3.0 |
Mucins/*analysis/chemistry | 2 | 66.0 |
Epithelium/immunology | 2 | 1.0 |
*Exons | 2 | 0.0 |
Mucins/chemistry/*genetics | 4 | 40.0 |
DNA, Complementary/analysis | 3 | 1.0 |
Epithelial Cells | 7 | 1.0 |
Mucins/*chemistry/genetics/physiology | 2 | 100.0 |
RNA/isolation & purification | 2 | 3.0 |
Colonic Neoplasms/chemistry/metabolism | 2 | 100.0 |
Cross Reactions | 2 | 0.0 |
Dimerization | 6 | 0.0 |
Immune Sera | 3 | 1.0 |
Subcellular Fractions | 2 | 1.0 |
Tunicamycin/pharmacology | 2 | 2.0 |
Ultracentrifugation | 4 | 2.0 |
Antigen-Antibody Reactions | 3 | 0.0 |
Epitope Mapping | 3 | 1.0 |
Adenocarcinoma, Mucinous/genetics/*metabolism/pathology | 2 | 66.0 |
Ki-67 Antigen/metabolism | 2 | 0.0 |
Colonic Neoplasms/genetics | 3 | 4.0 |
Macromolecular Substances | 4 | 0.0 |
Repetitive Sequences, Nucleic Acid | 16 | 1.0 |
Adenocarcinoma | 4 | 3.0 |
Colonic Neoplasms | 6 | 4.0 |
Glycosyltransferases/metabolism | 2 | 28.0 |
Sialic Acids/metabolism | 2 | 8.0 |
Guanidine | 2 | 7.0 |
Adenocarcinoma/classification/*metabolism/pathology | 4 | 80.0 |
Chromogranins/analysis | 2 | 3.0 |
Neprilysin/analysis | 3 | 5.0 |
Chromosomes, Human, Pair 11/*genetics | 3 | 1.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Genomic Library | 4 | 0.0 |
Plasmids | 3 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 2 | 0.0 |
Gastric Mucosa/chemistry | 4 | 23.0 |
Intestinal Mucosa/chemistry | 3 | 11.0 |
*Multigene Family | 4 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Goblet Cells/*pathology | 2 | 40.0 |
Blotting, Southern | 4 | 0.0 |
Colorectal Neoplasms/metabolism | 3 | 20.0 |
Mucins/*chemistry | 4 | 22.0 |
Peptides | 2 | 3.0 |
Neoplasm Metastasis | 5 | 0.0 |
CHO Cells | 3 | 0.0 |
Caco-2 Cells | 2 | 0.0 |
Hamsters | 4 | 0.0 |
Hybrid Cells | 3 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Pedigree | 3 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Antibodies, Monoclonal/*immunology | 4 | 0.0 |
Antibodies, Neoplasm/*immunology | 2 | 8.0 |
Colony Count, Microbial | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 3 | 0.0 |
Bile Ducts, Intrahepatic/metabolism | 2 | 100.0 |
CA-15-3 Antigen/immunology/*metabolism | 2 | 25.0 |
In Vitro | 4 | 0.0 |
Neoplasm Proteins/biosynthesis/*genetics | 3 | 3.0 |
Metaplasia/metabolism | 2 | 15.0 |
Trypsin/pharmacology | 2 | 1.0 |
Submandibular Gland/metabolism | 2 | 14.0 |
Pancreatic Neoplasms/genetics/*metabolism | 2 | 13.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Rhinitis/genetics/metabolism | 2 | 100.0 |
Intestine, Small/metabolism | 4 | 7.0 |
Protein Precursors/biosynthesis | 3 | 14.0 |
Carbohydrates/analysis | 2 | 3.0 |
Sequence Analysis | 2 | 0.0 |
Liver Neoplasms/*metabolism/secondary | 2 | 33.0 |
Introns | 3 | 0.0 |
Intestines/*chemistry | 3 | 60.0 |
Peptides/metabolism | 3 | 1.0 |
Severity of Illness Index | 3 | 0.0 |
Consensus Sequence | 4 | 0.0 |
Exons | 2 | 0.0 |
Mucous Membrane/metabolism | 3 | 9.0 |
Mucins/genetics/metabolism | 2 | 25.0 |
Nasal Mucosa/*metabolism | 3 | 15.0 |
Pancreatic Neoplasms/*genetics/metabolism/pathology | 3 | 15.0 |
Colon/pathology | 3 | 7.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Genes, ras | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Trachea/*metabolism | 4 | 23.0 |
Chromatography, Ion Exchange | 3 | 0.0 |
Glycoproteins/chemistry | 4 | 14.0 |
Glucosamine/metabolism | 3 | 11.0 |
Organ Culture Techniques | 2 | 0.0 |
Peptides/chemistry | 3 | 0.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Methotrexate/pharmacology | 2 | 2.0 |
RNA, Neoplasm/genetics | 6 | 1.0 |
DNA, Complementary/genetics/isolation & purification | 2 | 1.0 |
Oligonucleotide Probes/genetics | 2 | 1.0 |
Mucins/*biosynthesis/chemistry/genetics | 2 | 100.0 |
Neoplasm Recurrence, Local | 3 | 0.0 |
Amino Acids/metabolism | 2 | 2.0 |
Mucins/*analysis/*biosynthesis | 2 | 100.0 |
Mucins/*genetics/immunology | 2 | 66.0 |
Colonic Neoplasms/*metabolism | 4 | 5.0 |
Tumor Markers, Biological/genetics/*metabolism | 2 | 5.0 |
Apoptosis/physiology | 2 | 0.0 |
Forskolin/pharmacology | 3 | 0.0 |
Breast Neoplasms/genetics | 2 | 0.0 |
Calcimycin/pharmacology | 2 | 0.0 |
Monensin/pharmacology | 2 | 3.0 |
*Gastric Mucin | 6 | 75.0 |
Adenocarcinoma/genetics/metabolism | 2 | 10.0 |
Cluster Analysis | 2 | 1.0 |
RNA, Messenger/analysis/biosynthesis | 3 | 1.0 |
CA-15-3 Antigen | 5 | 5.0 |
Mucins/*biosynthesis/genetics/isolation & purification | 2 | 50.0 |
COS Cells | 3 | 0.0 |
*Consensus Sequence | 2 | 9.0 |
Protein Biosynthesis | 2 | 0.0 |
Bronchi/*metabolism | 4 | 12.0 |
Pancreas/metabolism | 3 | 3.0 |
RNA Probes | 2 | 1.0 |
Repetitive Sequences, Nucleic Acid/genetics | 2 | 2.0 |
RNA, Messenger/*analysis/genetics | 2 | 4.0 |
*Gene Expression Regulation, Neoplastic/drug effects | 2 | 3.0 |
Oligonucleotides, Antisense | 2 | 2.0 |
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1.0 |
RNA, Messenger/isolation & purification/metabolism | 2 | 10.0 |
*Proteins | 3 | 0.0 |
Cadherins/biosynthesis | 2 | 7.0 |
Linkage (Genetics) | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Respiratory System/metabolism | 2 | 20.0 |
Homeodomain Proteins/genetics/*metabolism | 2 | 1.0 |
Glycoproteins/biosynthesis | 2 | 6.0 |
Antigens, Neoplasm/analysis | 2 | 0.0 |
Peptide Biosynthesis | 2 | 4.0 |
Esophageal Neoplasms/*metabolism/pathology | 2 | 8.0 |
Neoplasms, Multiple Primary | 2 | 13.0 |
Mucins/*biosynthesis/*chemistry | 2 | 50.0 |
Hydrofluoric Acid/pharmacology | 2 | 100.0 |
